Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
9.97
+0.14 (1.42%)
At close: Oct 29, 2024, 4:00 PM
9.80
-0.17 (-1.71%)
After-hours: Oct 29, 2024, 6:36 PM EDT
Lexeo Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$22.14
Upside
+122.07%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +130.69% | Oct 25, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +130.69% | Aug 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $21 | Strong Buy | Maintains | $22 → $21 | +110.63% | Aug 13, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $24 | Buy | Reiterates | $24 | +140.72% | Aug 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +120.66% | Jul 16, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +130.69% | Jul 15, 2024 |
| Baird | Baird | Buy Initiates $28 | Buy | Initiates | $28 | +180.84% | Jun 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +120.66% | Jun 6, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $22 → $24 | Buy | Maintains | $22 → $24 | +140.72% | Mar 12, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +130.69% | Nov 28, 2023 |
| Leerink Partners | Leerink Partners | Buy Initiates $19 | Buy | Initiates | $19 | +90.57% | Nov 28, 2023 |
| RBC Capital | RBC Capital | Buy Initiates $22 | Buy | Initiates | $22 | +120.66% | Nov 28, 2023 |
| Stifel | Stifel | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +100.60% | Nov 28, 2023 |
| JP Morgan | JP Morgan | Buy Initiates $20 | Buy | Initiates | $20 | +100.60% | Nov 28, 2023 |